[
  {
    "report_key": "2026:q1",
    "period_label": "2026 Q1",
    "date": "2026-05-06",
    "title": "Kvartalsrapport Q1 2026",
    "original_title": "Infant Bacterial Therapeutics AB (publ) Delårsrapport 1 januari - 31 mars 2026",
    "category": "Interimsrapport",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b027354d8e44a5d55bc4685ce60a31680&lang=sv&src=listed",
    "language": "sv",
    "report_type": "interim-report",
    "fiscal_year": 2026,
    "quarter": "q1",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2026",
        "title": "Kvartalsrapport Q1 2026",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/aab98738e2c5e633c3f51d1ff0cf52426",
        "date": "2026-05-06",
        "period": "2026-q1",
        "form_type": "interim-report",
        "report_key": "2026:q1",
        "filename": "IBT_Delarsrapport_Q1_2026_SWE.pdf",
        "text_chars": 25715,
        "sha256": "60547f958272dd40ba2712e07317218b73088891e55b691618e32cfdcb697788",
        "url": "/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q1-2026",
        "absolute_url": "https://spela.port0.org/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q1-2026",
        "txt_url": "/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q1-2026/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q1-2026/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q1-2026/part-001.html",
            "chars": 25715
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2025:annual",
    "period_label": "2025 Årsredovisning",
    "date": "2026-03-27",
    "title": "Årsredovisning 2025",
    "original_title": "Infant Bacterial Therapeutics AB publicerar Årsredovisning för 2025",
    "category": "Bokslut och Verksamhetsberättelse",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=bb79125e01308503d8fb0682efb0e64c0&lang=sv&src=listed",
    "language": "sv",
    "report_type": "annual-report",
    "fiscal_year": 2025,
    "quarter": "annual",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-arsredovisning-2025",
        "title": "Årsredovisning 2025",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a8c22c84d7301089482c83358d64784a4",
        "date": "2026-03-27",
        "period": "2025-annual",
        "form_type": "annual-report",
        "report_key": "2025:annual",
        "filename": "IBT_AR_2025_SWE.pdf",
        "text_chars": 126960,
        "sha256": "57d5849913dcb69ecf4754806e59c338a346dfc9a40e3c06e522c8255e4d9c1a",
        "url": "/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-arsredovisning-2025",
        "absolute_url": "https://spela.port0.org/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-arsredovisning-2025",
        "txt_url": "/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-arsredovisning-2025/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-arsredovisning-2025/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-arsredovisning-2025/part-001.html",
            "chars": 126960
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2025:q4",
    "period_label": "2025 Q4",
    "date": "2026-02-06",
    "title": "Kvartalsrapport Q4 2025",
    "original_title": "Infant Bacterial Therapeutics AB (publ) Bokslutskommuniké 1 januari - 31 december 2025",
    "category": "Bokslutskommuniké",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b000eddc922590847a6e3ee0d56221b3f&lang=sv&src=listed",
    "language": "sv",
    "report_type": "year-end-report",
    "fiscal_year": 2025,
    "quarter": "q4",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2025",
        "title": "Kvartalsrapport Q4 2025",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a66490c3b1577450316a0e9ff1c7f1af0",
        "date": "2026-02-06",
        "period": "2025-q4",
        "form_type": "year-end-report",
        "report_key": "2025:q4",
        "filename": "IBT_Bokslutskommunike_Q4_2025_SWE.pdf",
        "text_chars": 23017,
        "sha256": "f0075fd94502b2a6d54a9ec3f7ad5ee50db8f09da508060f5cb663e1959987e9",
        "url": "/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q4-2025",
        "absolute_url": "https://spela.port0.org/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q4-2025",
        "txt_url": "/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q4-2025/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q4-2025/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q4-2025/part-001.html",
            "chars": 23017
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2025:q3",
    "period_label": "2025 Q3",
    "date": "2025-11-13",
    "title": "Kvartalsrapport Q3 2025",
    "original_title": "Infant Bacterial Therapeutics AB (publ) Delårsrapport 1 januari - 30 september 2025",
    "category": "Interimsrapport",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=bc6cede42db1d7a976b2e88e76bbfd15a&lang=sv&src=listed",
    "language": "sv",
    "report_type": "interim-report",
    "fiscal_year": 2025,
    "quarter": "q3",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2025",
        "title": "Kvartalsrapport Q3 2025",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a917c68d40817e6683d3ddbe39cc8ede0",
        "date": "2025-11-13",
        "period": "2025-q3",
        "form_type": "interim-report",
        "report_key": "2025:q3",
        "filename": "IBT_Delarsrapport_Q3_2025_SWE.pdf",
        "text_chars": 28703,
        "sha256": "eff505bc2ee8be453261fe103f9076d941f5b9abd186965a5e2d4bdc2dac5505",
        "url": "/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q3-2025",
        "absolute_url": "https://spela.port0.org/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q3-2025",
        "txt_url": "/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q3-2025/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q3-2025/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q3-2025/part-001.html",
            "chars": 28703
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2025:q2",
    "period_label": "2025 Q2",
    "date": "2025-08-20",
    "title": "Kvartalsrapport Q2 2025",
    "original_title": "Infant Bacterial Therapeutics AB (publ) Delårsrapport 1 januari - 30 juni 2025",
    "category": "Halvårsrapport",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b3b6d7c8e695faa8f16d807ea4db5b340&lang=sv&src=listed",
    "language": "sv",
    "report_type": "interim-report",
    "fiscal_year": 2025,
    "quarter": "q2",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2025",
        "title": "Kvartalsrapport Q2 2025",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a1b435d92c4f4ae2608ff1bc2cd7539a3",
        "date": "2025-08-20",
        "period": "2025-q2",
        "form_type": "interim-report",
        "report_key": "2025:q2",
        "filename": "IBT_Delarsrapport_Q2_2025_SWE.pdf",
        "text_chars": 29386,
        "sha256": "cb1be1894b069461b3f76ae27243aa2c1e06a97909be21597672f49f865e7cbd",
        "url": "/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q2-2025",
        "absolute_url": "https://spela.port0.org/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q2-2025",
        "txt_url": "/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q2-2025/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q2-2025/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q2-2025/part-001.html",
            "chars": 29386
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2025:q1",
    "period_label": "2025 Q1",
    "date": "2025-05-07",
    "title": "Kvartalsrapport Q1 2025",
    "original_title": "Infant Bacterial Therapeutics AB (publ) Delårsrapport 1 januari - 31 mars 2025",
    "category": "Interimsrapport",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b7812a17f37d874ba0372929cb127d527&lang=sv&src=listed",
    "language": "sv",
    "report_type": "interim-report",
    "fiscal_year": 2025,
    "quarter": "q1",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2025",
        "title": "Kvartalsrapport Q1 2025",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a697a551aa54bc2748df37c10092bee28",
        "date": "2025-05-07",
        "period": "2025-q1",
        "form_type": "interim-report",
        "report_key": "2025:q1",
        "filename": "IBT_Delarsrapport_Q1_2025_SWE.pdf",
        "text_chars": 23394,
        "sha256": "254e2c7f46096af3ba99a4b04ad8190770155a87929019b5f91f29ad23f09e0e",
        "url": "/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q1-2025",
        "absolute_url": "https://spela.port0.org/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q1-2025",
        "txt_url": "/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q1-2025/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q1-2025/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q1-2025/part-001.html",
            "chars": 23394
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2024:annual",
    "period_label": "2024 Årsredovisning",
    "date": "2025-03-27",
    "title": "Årsredovisning 2024",
    "original_title": "Infant Bacterial Therapeutics AB publicerar Årsredovisning för 2024",
    "category": "Bokslut och Verksamhetsberättelse",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=bdada50e058b5762e4fb9f8442f6ecf8a&lang=sv&src=listed",
    "language": "sv",
    "report_type": "annual-report",
    "fiscal_year": 2024,
    "quarter": "annual",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-arsredovisning-2024",
        "title": "Årsredovisning 2024",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a6f888496f180b76dd578e4bec19c9ca5",
        "date": "2025-03-27",
        "period": "2024-annual",
        "form_type": "annual-report",
        "report_key": "2024:annual",
        "filename": "IBT_AR_2024_SWE.pdf",
        "text_chars": 128182,
        "sha256": "e8ac50795bc8b094a5d257f04dfc2fd0ebaaa24f3678d4f1bf48188dc98dccbc",
        "url": "/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-arsredovisning-2024",
        "absolute_url": "https://spela.port0.org/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-arsredovisning-2024",
        "txt_url": "/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-arsredovisning-2024/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-arsredovisning-2024/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-arsredovisning-2024/part-001.html",
            "chars": 128182
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2024:q4",
    "period_label": "2024 Q4",
    "date": "2025-02-13",
    "title": "Kvartalsrapport Q4 2024",
    "original_title": "Infant Bacterial Therapeutics AB (publ) Bokslutskommuniké 1 januari - 31 december 2024",
    "category": "Bokslutskommuniké",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b219653b47b21d8d37022e6efc14f4497&lang=sv&src=listed",
    "language": "sv",
    "report_type": "year-end-report",
    "fiscal_year": 2024,
    "quarter": "q4",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2024",
        "title": "Kvartalsrapport Q4 2024",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a75ff970d41a7f900c40093f0e44f40ca",
        "date": "2025-02-13",
        "period": "2024-q4",
        "form_type": "year-end-report",
        "report_key": "2024:q4",
        "filename": "IBT_Bokslutskommunike_2024_SWE.pdf",
        "text_chars": 28388,
        "sha256": "60673f59815137502ce0484f4dff8728d5b74a7739ce3cc53291776654892714",
        "url": "/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q4-2024",
        "absolute_url": "https://spela.port0.org/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q4-2024",
        "txt_url": "/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q4-2024/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q4-2024/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q4-2024/part-001.html",
            "chars": 28388
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2024:q3",
    "period_label": "2024 Q3",
    "date": "2024-11-14",
    "title": "Kvartalsrapport Q3 2024",
    "original_title": "Infant Bacterial Therapeutics AB (publ) Delårsrapport 1 januari - 30 september 2024",
    "category": "Interimsrapport",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=be2a184557531627f12b4c743e4162be9&lang=sv&src=listed",
    "language": "sv",
    "report_type": "interim-report",
    "fiscal_year": 2024,
    "quarter": "q3",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2024",
        "title": "Kvartalsrapport Q3 2024",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/ac8f2b73a9b8bf06d95baa057ee338fc3",
        "date": "2024-11-14",
        "period": "2024-q3",
        "form_type": "interim-report",
        "report_key": "2024:q3",
        "filename": "IBT_Q3_2024_SWE.pdf",
        "text_chars": 31917,
        "sha256": "8fa6fb15345a38a89d633e003181c4d9316286be92b6fe92e2ee91ea19dfdb52",
        "url": "/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q3-2024",
        "absolute_url": "https://spela.port0.org/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q3-2024",
        "txt_url": "/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q3-2024/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q3-2024/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q3-2024/part-001.html",
            "chars": 31917
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2024:q2",
    "period_label": "2024 Q2",
    "date": "2024-08-28",
    "title": "Kvartalsrapport Q2 2024",
    "original_title": "Infant Bacterial Therapeutics AB (publ), Delårsrapport 1 januari - 30 juni 2024",
    "category": "Halvårsrapport",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b879b094182889bce0984b3e5d04e5f11&lang=sv&src=listed",
    "language": "sv",
    "report_type": "interim-report",
    "fiscal_year": 2024,
    "quarter": "q2",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2024",
        "title": "Kvartalsrapport Q2 2024",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a0cc900329bea0b4d50080bd6355bda22",
        "date": "2024-08-28",
        "period": "2024-q2",
        "form_type": "interim-report",
        "report_key": "2024:q2",
        "filename": "IBT_Q2_2024_SWE.pdf",
        "text_chars": 30065,
        "sha256": "828207bdc489450224f095a0e200679a215d28b9d73bdc3f17a46a77068ee59b",
        "url": "/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q2-2024",
        "absolute_url": "https://spela.port0.org/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q2-2024",
        "txt_url": "/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q2-2024/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q2-2024/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q2-2024/part-001.html",
            "chars": 30065
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2024:q1",
    "period_label": "2024 Q1",
    "date": "2024-05-07",
    "title": "Kvartalsrapport Q1 2024",
    "original_title": "Infant Bacterial Therapeutics AB (publ) Delårsrapport 1 januari - 31 mars 2024",
    "category": "Interimsrapport",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b7d0f45700fa593a9e0b100e952ba66f4&lang=sv&src=listed",
    "language": "sv",
    "report_type": "interim-report",
    "fiscal_year": 2024,
    "quarter": "q1",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2024",
        "title": "Kvartalsrapport Q1 2024",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/af20d6c8b8ab9d41a8631f94b247f5b51",
        "date": "2024-05-07",
        "period": "2024-q1",
        "form_type": "interim-report",
        "report_key": "2024:q1",
        "filename": "IBT_Q1_2024_SWE.pdf",
        "text_chars": 27735,
        "sha256": "6ed837bdc6bdb7a412198cd615dc48f759cf9381b4e368d1d10d666e84a49bc1",
        "url": "/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q1-2024",
        "absolute_url": "https://spela.port0.org/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q1-2024",
        "txt_url": "/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q1-2024/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q1-2024/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q1-2024/part-001.html",
            "chars": 27735
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2023:annual",
    "period_label": "2023 Årsredovisning",
    "date": "2024-03-25",
    "title": "Årsredovisning 2023",
    "original_title": "Infant Bacterial Therapeutics AB publicerar Årsredovisning för räkenskapsåret 2023",
    "category": "Bokslut och Verksamhetsberättelse",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=ba67f73ce2150c6f2b071c09711935ca8&lang=sv&src=listed",
    "language": "sv",
    "report_type": "annual-report",
    "fiscal_year": 2023,
    "quarter": "annual",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-arsredovisning-2023",
        "title": "Årsredovisning 2023",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a83118a0ffca658a51b7661b06f9d367b",
        "date": "2024-03-25",
        "period": "2023-annual",
        "form_type": "annual-report",
        "report_key": "2023:annual",
        "filename": "IBT_Arsredovisning_2023.pdf",
        "text_chars": 143392,
        "sha256": "e0e4c6cdf0708d6b045abc77f70fe01082123b17c52426cdd1cd9b385347ca0c",
        "url": "/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-arsredovisning-2023",
        "absolute_url": "https://spela.port0.org/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-arsredovisning-2023",
        "txt_url": "/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-arsredovisning-2023/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-arsredovisning-2023/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-arsredovisning-2023/part-001.html",
            "chars": 143392
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2023:q4",
    "period_label": "2023 Q4",
    "date": "2024-02-08",
    "title": "Kvartalsrapport Q4 2023",
    "original_title": "Infant Bacterial Therapeutics AB (publ), Bokslutskommuniké 1 januari - 31 December 2023",
    "category": "Bokslutskommuniké",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b2c256b9cecd4622a19b3fb7f0696c6e7&lang=sv&src=listed",
    "language": "sv",
    "report_type": "year-end-report",
    "fiscal_year": 2023,
    "quarter": "q4",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2023",
        "title": "Kvartalsrapport Q4 2023",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a32e4c171dc57857ab695a042d279a1ad",
        "date": "2024-02-08",
        "period": "2023-q4",
        "form_type": "year-end-report",
        "report_key": "2023:q4",
        "filename": "IBT_Bokslutskommumike_2023_SWE.pdf",
        "text_chars": 36086,
        "sha256": "0d62610a160ae9194d24a678fc256c4156241f31155955b7ddd6ebee83312994",
        "url": "/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q4-2023",
        "absolute_url": "https://spela.port0.org/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q4-2023",
        "txt_url": "/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q4-2023/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q4-2023/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q4-2023/part-001.html",
            "chars": 36086
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2023:q3",
    "period_label": "2023 Q3",
    "date": "2023-11-10",
    "title": "Kvartalsrapport Q3 2023",
    "original_title": "Infant Bacterial Therapeutics AB (publ), Delårsrapport 1 januari - 30 September 2023",
    "category": "Interimsrapport",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b7670857707eac3635c8c61428b078d49&lang=sv&src=listed",
    "language": "sv",
    "report_type": "interim-report",
    "fiscal_year": 2023,
    "quarter": "q3",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2023",
        "title": "Kvartalsrapport Q3 2023",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/acbf891c15f9e41312f319d0ddc1594b3",
        "date": "2023-11-10",
        "period": "2023-q3",
        "form_type": "interim-report",
        "report_key": "2023:q3",
        "filename": "IBT_Q3_2023_SWE.pdf",
        "text_chars": 39437,
        "sha256": "f05f5d227315ed3ee516f2036ecf70a3ffbd03bf221bb18effe2dd19f6987e40",
        "url": "/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q3-2023",
        "absolute_url": "https://spela.port0.org/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q3-2023",
        "txt_url": "/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q3-2023/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q3-2023/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q3-2023/part-001.html",
            "chars": 39437
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2023:q2",
    "period_label": "2023 Q2",
    "date": "2023-08-25",
    "title": "Kvartalsrapport Q2 2023",
    "original_title": "Infant Bacterial Therapeutics AB (publ), Delårsrapport 1 januari - 30 juni 2023",
    "category": "Halvårsrapport",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b40d0cf9c5bfd2045fc4f738fb5be832e&lang=sv&src=listed",
    "language": "sv",
    "report_type": "interim-report",
    "fiscal_year": 2023,
    "quarter": "q2",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2023",
        "title": "Kvartalsrapport Q2 2023",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/ab00cd4908db4148bfe82b553f3543eba",
        "date": "2023-08-25",
        "period": "2023-q2",
        "form_type": "interim-report",
        "report_key": "2023:q2",
        "filename": "IBT_Q2_2023_SWE.pdf",
        "text_chars": 35246,
        "sha256": "4dfb488ba5020d824c3e34b05c4e7f98e2e5239bdfc522ec7c0276ecec505a8a",
        "url": "/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q2-2023",
        "absolute_url": "https://spela.port0.org/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q2-2023",
        "txt_url": "/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q2-2023/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q2-2023/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q2-2023/part-001.html",
            "chars": 35246
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2023:q1",
    "period_label": "2023 Q1",
    "date": "2023-05-08",
    "title": "Kvartalsrapport Q1 2023",
    "original_title": "Infant Bacterial Therapeutics AB (publ), Delårsrapport 1 januari - 31 mars 2023",
    "category": "Interimsrapport",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=bf428a2811566892e1897cbddae12e0ec&lang=sv&src=listed",
    "language": "sv",
    "report_type": "interim-report",
    "fiscal_year": 2023,
    "quarter": "q1",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2023",
        "title": "Kvartalsrapport Q1 2023",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/ae1ad6598b6277e4600d2810e334d2c8f",
        "date": "2023-05-08",
        "period": "2023-q1",
        "form_type": "interim-report",
        "report_key": "2023:q1",
        "filename": "IBT_Q1_2023_SWE.pdf",
        "text_chars": 28232,
        "sha256": "ab30a5ae58ec8f12c3625d739c21cd62e25f33078af1b4aba15c0931ed6806bc",
        "url": "/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q1-2023",
        "absolute_url": "https://spela.port0.org/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q1-2023",
        "txt_url": "/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q1-2023/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q1-2023/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q1-2023/part-001.html",
            "chars": 28232
          }
        ]
      }
    ],
    "alternatives": []
  }
]